Quale sarebbe il prezzo per Poolbeg Pharma PLC (POLB)

Il prezzo per Poolbeg Pharma PLC (POLB) è $0.11565963

Qual è la capitalizzazione di mercato per Poolbeg Pharma PLC (POLB)

La capitalizzazione di mercato per Poolbeg Pharma PLC (POLB) è $882.99K

Poolbeg Pharma PLC (POLB) Prezzo e Capitalizzazione di Mercato

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Il prezzo per POLB	Attivo B	Capitalizzazione del mercato a B	Risultati
$714,304 $882.99K	NVDA	$5.453T	+617,591,455.16%
$587,908 $882.99K	AAPL	$4.488T	+508,308,899.16%
$545,056 $882.99K	GOOG	$4.161T	+471,258,491.05%
$484,422 $882.99K	MSFT	$3.698T	+418,834,225.10%
$371,408 $882.99K	AMZN	$2.835T	+321,121,244.61%

Il prezzo per POLB

Attivo B

Capitalizzazione del mercato a B

Risultati

$714,304 $882.99K